Project Grant R01CA292482
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$595K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
This $414,446 federal Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) will fund a study to examine the effectiveness of a group-based videoconference intervention to increase moderate to vigorous physical activity (MVPA) among cancer survivors. The 12-week intervention will provide twice-weekly instructor-led group-based aerobic and resistance exercise sessions, as well as PA behavior change discussion sessions, all...
This $671,757 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) will fund a pragmatic, multicenter randomized controlled trial at Virginia Commonwealth University (VCU). The study aims to test whether a tailored home-based physical activity intervention, delivered alongside a healthy living program, can help preserve exercise capacity, left ventricular function, and health-related quality of life, while...
This Project Grant award of $748,174 from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) supports a randomized clinical trial to evaluate the effectiveness of a telehealth intervention called "REVITALIZE" in reducing fatigue interference among adults with advanced ovarian cancer taking PARP inhibitor treatments. The study, led by the Dana-Farber Cancer Institute, Inc. in collaboration with the University of Colorado, aims to assess the...
This federal Project Grant award, provided by the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398), supports a research study to examine physical activity promotion intervention outcomes, barriers, and facilitators in breast cancer survivors experiencing cancer-related fatigue.
The $130,001 award to Northwestern University will fund secondary quantitative data analyses from the Fit2Thrive study, an mHealth physical activity intervention for breast cancer...
This is a U34 Clinical Trials Planning Grant awarded by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to the Dana-Farber Cancer Institute (DFCI) for $294,787. The grant, titled "DISTANCE-BASED EXERCISE TO PRESERVE FUNCTION AND PREVENT DISABILITY (DEFEND)", aims to develop a scalable, technology-enabled exercise intervention to improve physical function and reduce treatment-related side effects in cancer survivors, particularly vulnerable populations. The...
This $166,000 federal Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) will support research to examine whether implicit attitudes towards physical activity can be experimentally manipulated through affect-based intervention strategies delivered via interactive mobile technology. The University of Southern California is the prime awardee and will explore how real-time measures of implicit attitudes during daily life among...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $663,428 to the University of Colorado-Denver to partner with primary care clinics in Colorado to address inequities in behavioral cancer risks and unmet social needs. The project aims to evaluate the comparative effectiveness of two implementation strategy bundles to deliver the "My Own Health Report" (MOHR) web-based intervention, which screens for...
This $140,828 Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) supports research to develop and test implementation strategies for integrating built environment approaches to increase physical activity in communities served by the National Cooperative Extension System.
The primary grantee, CHN Nebraska, will work with Montana State University as a collaborative sub-awardee to systematically select and tailor implementation...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will fund the adaptation and preliminary evaluation of the "ENERGIZE-MBC" cognitive behavioral therapy intervention for fatigue among women with metastatic breast cancer treated with CDK4/6 inhibitors.
The $638,326 award will support three key objectives: 1) adapting an existing evidence-based cognitive behavioral therapy for fatigue intervention to meet the specific needs...
The National Cancer Institute (NCI) awarded a $656,014 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to The Ohio State University to conduct a randomized clinical trial of a telemedicine-mHealth symptom cluster intervention for advanced cancer patients in underserved rural communities. The primary goal is to improve sleep difficulties, worry-anxiety, depression, and fatigue symptoms, functional status, and quality of life for this patient population. The 5-year study will...